Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry

BACKGROUND: Ticagrelor reduces ischaemic end points in acute coronary syndromes. However, outcomes of ticagrelor versus clopidogrel in real‐world patients with acute coronary syndromes treated with percutaneous coronary intervention (PCI) remain unclear. We sought to examine whether treatment with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Völz, Sebastian, Petursson, Petur, Odenstedt, Jacob, Ioanes, Dan, Haraldsson, Inger, Angerås, Oskar, Dworeck, Christian, Hirlekar, Geir, Myredal, Anna, Albertsson, Per, Råmunddal, Truls, Redfors, Björn, Omerovic, Elmir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660716/
https://www.ncbi.nlm.nih.gov/pubmed/32662350
http://dx.doi.org/10.1161/JAHA.119.015990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660716/
https://www.ncbi.nlm.nih.gov/pubmed/32662350
http://dx.doi.org/10.1161/JAHA.119.015990

Ejemplares similares